[Use of delayed-action high-dosage parenteral 6-methyl-prednisolone in oncology].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001066:Appetite / Q000187:drug effects; D001859:Bone Neoplasms / Q000188:drug therapy; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007273:Injections, Intramuscular; D008175:Lung Neoplasms / Q000188:drug therapy; D008207:Lymphatic Metastasis; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D012516:Osteosarcoma / Q000188:drug therapy
D003692:Delayed-Action Preparations; D008775:Methylprednisolone
Sull'uso per via parenteral del 6-metil-prednisolone in forma ritardo e ad alte dosi in oncologia.